ClinicalTrials.gov
ClinicalTrials.gov Menu

RO4929097 and Capecitabine in Treating Patients With Refractory Solid Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01158274
Recruitment Status : Completed
First Posted : July 8, 2010
Last Update Posted : November 7, 2014
Sponsor:
Information provided by (Responsible Party):
National Cancer Institute (NCI)

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : August 2012
  Study Completion Date : No date given